IL120669A - Benzoheterocyclic benzylamine derivatives and pharmaceutical compositions containing them - Google Patents
Benzoheterocyclic benzylamine derivatives and pharmaceutical compositions containing themInfo
- Publication number
- IL120669A IL120669A IL12066997A IL12066997A IL120669A IL 120669 A IL120669 A IL 120669A IL 12066997 A IL12066997 A IL 12066997A IL 12066997 A IL12066997 A IL 12066997A IL 120669 A IL120669 A IL 120669A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- benzisoxazol
- hydrogen
- ealkyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96201065 | 1996-04-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL120669A0 IL120669A0 (en) | 1997-08-14 |
| IL120669A true IL120669A (en) | 2001-04-30 |
Family
ID=8223896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12066997A IL120669A (en) | 1996-04-19 | 1997-04-15 | Benzoheterocyclic benzylamine derivatives and pharmaceutical compositions containing them |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0898566B1 (pl) |
| JP (1) | JP4008033B2 (pl) |
| CN (1) | CN1139580C (pl) |
| AR (1) | AR006719A1 (pl) |
| AT (1) | ATE227278T1 (pl) |
| AU (1) | AU725847B2 (pl) |
| BR (1) | BR9708790A (pl) |
| CA (1) | CA2251820C (pl) |
| CZ (1) | CZ295747B6 (pl) |
| DE (1) | DE69716896T2 (pl) |
| DK (1) | DK0898566T3 (pl) |
| ES (1) | ES2186888T3 (pl) |
| HU (1) | HU224637B1 (pl) |
| ID (1) | ID17723A (pl) |
| IL (1) | IL120669A (pl) |
| NO (1) | NO311976B1 (pl) |
| NZ (1) | NZ332334A (pl) |
| PL (1) | PL192561B1 (pl) |
| PT (1) | PT898566E (pl) |
| RU (1) | RU2179553C2 (pl) |
| TR (1) | TR199802104T2 (pl) |
| TW (1) | TW498070B (pl) |
| WO (1) | WO1997040027A1 (pl) |
| ZA (1) | ZA973209B (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080773A (en) * | 1997-10-14 | 2000-06-27 | Akzo Nobel, N.V. | Benzylamine derivatives which are useful in treating psychiatric disorders |
| US6342533B1 (en) | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
| US7125903B1 (en) | 1999-09-14 | 2006-10-24 | Aventis Pharmaceuticals Inc. | Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists |
| HUP0202706A3 (en) * | 1999-09-14 | 2004-12-28 | Aventis Pharmaceuticals Inc Br | Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists, their intermediates, process for their preparation and pharmaceutical compositions containing them |
| US7253165B2 (en) | 1999-09-14 | 2007-08-07 | Aventis Pharmaceuticals Inc. | Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists |
| US7091199B1 (en) | 1999-09-14 | 2006-08-15 | Aventis Pharmaceuticals Inc. | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
| RU2354648C2 (ru) * | 2002-07-19 | 2009-05-10 | Мемори Фармасьютиклз Корпорейшн | Соединения 6-амино-1н-индазола и 4-аминобензофурана в качестве ингибиторов фосфодиэстеразы 4 |
| DE602004025354D1 (de) * | 2003-08-14 | 2010-03-18 | Hoffmann La Roche | Gabanerge modulatoren |
| GB0321538D0 (en) * | 2003-09-13 | 2003-10-15 | Glaxo Group Ltd | Therapeutically useful compounds |
| EP1976513B1 (en) * | 2006-01-06 | 2016-08-24 | Sunovion Pharmaceuticals Inc. | Cycloalkylamines as monoamine reuptake inhibitors |
| EP1925305A1 (en) * | 2006-10-23 | 2008-05-28 | N.V. Organon | Ih channel inhibitors for the promotion of wakefulness |
| BRPI0923476A2 (pt) * | 2008-12-24 | 2016-01-19 | Astrazeneca Ab | composto, métodos para tratar depressão em um ser humano, e grande distúrbio depressivo, e, composição farmacêutica |
| US8637551B2 (en) | 2009-07-07 | 2014-01-28 | Merck Sharp & Dohme B.V. | 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives |
| CN102942464B (zh) * | 2012-12-06 | 2015-04-08 | 西北师范大学 | 化合物1-(2-卤苯基)-3-甲基-丁酮-1的合成方法 |
| CN112300061B (zh) * | 2020-10-06 | 2022-02-18 | 大连理工大学 | 一种含氮杂环二芳酮化合物的制备方法 |
| GB202103012D0 (en) | 2021-03-03 | 2021-04-14 | King S College London | Compounds |
| GB202103017D0 (en) | 2021-03-03 | 2021-04-14 | King S College London | Compounds |
| GB202103008D0 (en) | 2021-03-03 | 2021-04-14 | King S College London | Compounds |
| CN117567334A (zh) * | 2022-08-08 | 2024-02-20 | 山东康乔生物科技有限公司 | 一种苄胺类化合物的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4980365A (en) * | 1987-07-13 | 1990-12-25 | Hoechst-Roussel Pharmaceuticals Inc. | N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents |
| FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-04-15 EP EP97919371A patent/EP0898566B1/en not_active Expired - Lifetime
- 1997-04-15 NZ NZ332334A patent/NZ332334A/en not_active IP Right Cessation
- 1997-04-15 AT AT97919371T patent/ATE227278T1/de active
- 1997-04-15 CZ CZ19983349A patent/CZ295747B6/cs not_active IP Right Cessation
- 1997-04-15 RU RU98120691/04A patent/RU2179553C2/ru not_active IP Right Cessation
- 1997-04-15 BR BR9708790A patent/BR9708790A/pt not_active Application Discontinuation
- 1997-04-15 TR TR1998/02104T patent/TR199802104T2/xx unknown
- 1997-04-15 JP JP53769997A patent/JP4008033B2/ja not_active Expired - Lifetime
- 1997-04-15 PT PT97919371T patent/PT898566E/pt unknown
- 1997-04-15 DE DE69716896T patent/DE69716896T2/de not_active Expired - Lifetime
- 1997-04-15 CN CNB971947376A patent/CN1139580C/zh not_active Expired - Lifetime
- 1997-04-15 ZA ZA9703209A patent/ZA973209B/xx unknown
- 1997-04-15 CA CA002251820A patent/CA2251820C/en not_active Expired - Lifetime
- 1997-04-15 IL IL12066997A patent/IL120669A/en not_active IP Right Cessation
- 1997-04-15 PL PL329348A patent/PL192561B1/pl not_active IP Right Cessation
- 1997-04-15 WO PCT/EP1997/001904 patent/WO1997040027A1/en not_active Ceased
- 1997-04-15 ES ES97919371T patent/ES2186888T3/es not_active Expired - Lifetime
- 1997-04-15 HU HU9901434A patent/HU224637B1/hu not_active IP Right Cessation
- 1997-04-15 AU AU23870/97A patent/AU725847B2/en not_active Expired
- 1997-04-15 DK DK97919371T patent/DK0898566T3/da active
- 1997-04-19 TW TW086105111A patent/TW498070B/zh not_active IP Right Cessation
- 1997-04-21 ID IDP971328A patent/ID17723A/id unknown
- 1997-04-21 AR ARP970101597A patent/AR006719A1/es active IP Right Grant
-
1998
- 1998-10-16 NO NO19984836A patent/NO311976B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0898566B1 (en) | Substituted benzylamines and their use for the treatment of depression | |
| KR102662215B1 (ko) | 치환된 피라졸로(1,5-a)피리미딘 및 의학적 장애의 치료에서의 그의 용도 | |
| US7538105B2 (en) | Anti-infective agents | |
| LU84070A1 (fr) | Derives phenylcyclobutyliques,leur procede de preparation et leur application therapeutique | |
| HU198030B (en) | Process for production of derivatives of benzotiasole and benzotiophen and medical preparatives containing these compounds as active substance | |
| WO2005014553A1 (en) | Novel gamma-secretase inhibitors | |
| TW201107322A (en) | (Dihydro)imidazoiso[5,1-a]quinolines | |
| MXPA03008117A (es) | Derivados heterociclicos para el tratamiento del cancer y otras enfermedades proliferativas. | |
| IL136723A (en) | Arylpiperazines are active in serotonin A1 receptors | |
| JP2005511516A (ja) | 選択的ｒｘｒリガンド | |
| US5079246A (en) | Novel indoloquinlones | |
| US6313139B1 (en) | Benzylamine derivatives which are useful in treating psychiatric disorders | |
| US5411955A (en) | Thiadiazinecarboxamide derivatives, processes for their preparation and pharmaceuticals | |
| JP6518692B2 (ja) | 多環式ｈｅｒｇ活性化剤 | |
| JPH02223570A (ja) | ２―イミノ―６―ポリフルオロアルコキシベンゾチアゾール誘導体類、それらの製造およびそれらを含有している薬学的組成物 | |
| TW201309705A (zh) | 作為傑納斯（ｊａｎｕｓ）激酶抑制劑之雜環化合物 | |
| KR100498823B1 (ko) | 치환된벤질아민및이를우울증의치료에사용한방법 | |
| HK1018271B (en) | Substituted benzylamines and their use for the treatment of depression | |
| JP4339939B2 (ja) | テトラヒドロイミダゾ〔２，１−ａ〕イソキノリン誘導体 | |
| JP2010504943A (ja) | ピリドオキサゼピンプロゲステロン受容体モジュレータ | |
| US20040229910A1 (en) | Therapeutic compounds | |
| EA029430B1 (ru) | Производные 1-сульфонилпиперидина в качестве модуляторов рецепторов прокинетицина | |
| MXPA98005243A (en) | Derivatives of tetrahidroimidazo [2,1-a] isoquinol | |
| HUP9902949A2 (hu) | Aril-szubsztituált ciklusos aminok, mint szelektív dopamin D3 receptor ligandumok |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |